Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Cell-Therapy Technology Institute Inc.
DescriptionDC and tumor cell fusion vaccine with IL12 as adjuvant
Molecular Target Interleukin-12 (IL-12)
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today